MEDA Pharma GmbH & Co. KG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Subsidiary
- Established
- 1919-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.medapharma.de
Aldara for the Treatment of Large and/or Multiple sBCC
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2022-02-22
- Lead Sponsor
- MEDA Pharma GmbH & Co. KG
- Target Recruit Count
- 111
- Registration Number
- NCT00189280
- Locations
- 🇫🇷
Service de DermatologieHôpital Dupuytren, Limoges, France
Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2022-02-07
- Lead Sponsor
- MEDA Pharma GmbH & Co. KG
- Target Recruit Count
- 128
- Registration Number
- NCT00189293
- Locations
- 🇮🇹
Unità Operativa di Ginecologia Oncologica, RCCS Ospedale Oncologico, Bari, Italy
🇮🇹Servizio Autonomo di Diagnosi Precoce dei Tumori Ginecologici Ospedale Vittorio Emanuele, Catania, Italy
🇮🇹Clinica Ostetrica Ginecologica, Ospedale Careggi, Firenze, Italy
A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma
Phase 3
Completed
- Conditions
- Basal Cell Carcinoma
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2022-02-07
- Lead Sponsor
- MEDA Pharma GmbH & Co. KG
- Target Recruit Count
- 160
- Registration Number
- NCT00189241
- Locations
- 🇩🇪
Univertätsklinik für Dermatologie und Venerologie, Magedeburg, Germany
5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic Dermatitis
Phase 3
Completed
- Conditions
- Atopic Dermatitis
- Interventions
- Drug: Topical corticosteroids
- First Posted Date
- 2005-07-18
- Last Posted Date
- 2022-02-11
- Lead Sponsor
- MEDA Pharma GmbH & Co. KG
- Target Recruit Count
- 2418
- Registration Number
- NCT00120523
- Locations
- 🇺🇸
Children's Skin Center, Miami, Florida, United States
🇺🇸Dermatology Research Associates, Cincinnati, Ohio, United States
🇩🇪Novartis, Investigative Site, Germany
© Copyright 2025. All Rights Reserved by MedPath